Joseph Nahas, MD

Article

Safety Profile of Mutant EGFR-TK Inhibitors in Advanced Non–Small Cell Lung Cancer: A Meta-analysis

Author:: Joseph Nahas, MD

Publish date: August 15, 2022

This meta-analysis showed that mutant epidermal growth factor receptor–tyrosine kinase inhibitors have an incidence of adverse effects that is less...